Actively Recruiting
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
Led by The Cooper Health System · Updated on 2021-11-12
34
Participants Needed
1
Research Sites
165 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will assess analgesia after robotic lung surgery. Subjects will be randomized to receive wound infiltration and intercostal nerve block with either liposomal bupivacaine or bupivacaine/epinephrine + dexamethasone. Liposomal bupivacaine is a newer local anesthetic product and has not been compared to a combination of bupivacaine/epinephrine + dexamethasone in the context of pain control after robotic lung surgery.
CONDITIONS
Official Title
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Undergoing robotic wedge resection or lobectomy for lung mass(es)
You will not qualify if you...
- Emergency case
- History of opiate abuse
- Chronic pain syndrome
- Intravenous drug use
- Chronic use of oral steroids
- Pregnancy
- Imprisonment
- Body weight lower than 70 kg
- Liver failure
- Uninsured patients
- Non-verbal patients or patients unable to rate their pain on a visual analogue pain scale
- History of allergic reaction to any of the drugs used in the study: bupivacaine, liposomal bupivacaine, dexamethasone
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cooper University Hospital
Camden, New Jersey, United States, 08103
Actively Recruiting
Research Team
N
Noud van Helmond, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here